Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.03.22.713503

Agent-Based Modeling of Idiopathic Lung Fibrosis and Mechanistic Treatments

Abstract

Agent-based modeling (ABM) is a computational method for predicting the emergent outcomes of interacting, autonomous individuals in a complex system. Here, ABM is used to simulate interactions between fibroblast and myofibroblast cells during idiopathic pulmonary fibrosis (IPF) in alveolar tissue microenvironments. These microenvironments are derived from histology of a healthy human lung sample and moderate- and severe-IPF lung samples. Fibroblast differentiation, cell migration, and collagen secretion in response to the spatial distribution of the cytokine transforming growth factor-beta are captured in the ABM using NetLogo software. Results are presented from one simulated year without treatment and with mechanisms representing treatment by pirfenidone and pentoxifylline, alone and in combination. A total of 180 in silico experiments are run, analyzed, and compared in a high-throughput workflow. The effects of the initial number of fibroblasts and treatment scenarios on various metrics related to collagen accumulation and collagen invasion into alveolar regions are determined. The ABM and the analysis files are shared to facilitate model reuse. By integrating computational modeling of IPF and therapeutics, this research aims to improve understanding of fibrosis progression and assess the efficacy of novel and existing treatments targeting different mechanisms to inform decision-making for IPF treatment.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Gunputh, N. D., Kilikian, E., Miranda, C. A., Peirce, S. M., Ford Versypt, A. N.. 2026-03-25. Agent-Based Modeling of Idiopathic Lung Fibrosis and Mechanistic Treatments. https://doi.org/10.64898/2026.03.22.713503

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Multi-omic longitudinal profiling of companion dogs reveals cross-omic coordination and structured aging trajectories

Aging is a systems-level biological process shaped by coordinated changes across molecular, physiological, and environmental domains, yet how these domains interact and impact aging remains poorly understood. Companion dogs offer a powerful model for addressing this gap, combining shared human environments with diversity in genetics, lifespan, and disease susceptibility. Here, we present a longitudinal multi-omic analysis of aging in 965 companion dogs from the Dog Aging Project, integrating microbiome, epigenome, blood metabolome, and immune phenotyping with extensive clinical, environmental, and lifestyle surveys. We reveal an interconnected cross-omic architecture, with age emerging as the dominant axis of biological variation. We further identify a predictive multi-omic aging signature, distinguish linear from non-linear aging trajectories, uncover breed size-dependent dynamics, and characterize omic-specific mortality risk. Collectively, our findings reveal organizing principles of aging, many paralleling human observations, provide a unique resource for integrative geroscience, and establish dogs as a translational model for aging research.

systems biology↗

Benchmarking temporal causal discovery for fully and partially observed biochemical kinetic models

Accurately reconstructing networks of biochemical reactions is a crucial yet unsolved problem for leveraging advances in experimental techniques that track intracellular dynamics in a time-resolved fashion. This task is further challenged by the fact that we typically observe only part of the system, while many variables shaping the dynamics remain unobserved. Causal discovery methods can infer causal relations from purely observational data and account for unobserved variables. They therefore hold promise for yielding faithful, mechanistically interpretable representations of underlying biochemical interactions, but their potential in this context remains underexplored. In this work, we provide a systematic benchmark of state-of-the-art temporal causal discovery methods (tMIIC, PCMCI+/LPCMCI and SVAR-FCI) on time-series data from simulations of biochemical kinetics of mass action and Michaelis-Menten type modelled as systems of nonlinear stochastic differential equations, including an experimentally calibrated model of the epidermal growth factor receptor signalling network. By selectively omitting data, we consider the problem of reconstructing these networks in the presence of both latent confounders and unobserved species participating in reactions. We find that tMIIC and PCMCI+/LPCMCI achieve the highest overall prediction quality, with tMIIC able to handle larger samples within the same runtime budget. We identify, as the main condition for optimal performance of causal discovery, the consistency between data-sampling regimes (sampling intervals, trajectory length) and the typical timescales of the system. We establish that causal discovery can detect latent confounders via bidirected edges and unobserved species via time-delayed edges, locating hidden effects and encoding information on their typical timescales, provided that the data sampling guarantees adequate temporal resolution. As such, our results can guide the choice of hyperparameters in causal discovery algorithms and of data-sampling regimes to optimize network-reconstruction performance.

systems biology↗

Dynamic multi-omics analysis of Adenovirus-induced rAAV-producing stable cell lines reveals the interplay between adenoviral infection and host cell metabolism

Recombinant adeno-associated viruses (rAAV) are invaluable delivery vehicles for gene therapy. However, to make rAAV-based therapies more accessible, there is a need to increase rAAV titers. Here we analyze the phenotypic variation among 30 Adenovirus-induced stably-transfected human producer cell clones to identify metabolic signatures associated with high vs low rAAV production. Exometabolomic characterization revealed decreased amino acid consumption in higher producers. Analysis of RNA-Seq data in the context of a genome-scale metabolic model identified upregulated carnosine biosynthesis-associated pathways during the first 6 hours post infection with adenovirus, relative to uninfected growth. Meanwhile, late infection timepoints exhibited increased amino acid release and de novo biosynthesis of serine, glycine, and arginine. Moreover, high producers decreased expression of genes linked with cholesterol biosynthesis and increased HMG-CoA degradation via HMGCL. Furthermore, sphingosine and ceramide biosynthesis genes were altered in high-producers in directions previously reported to resist cell death and suppress immune signaling. Overall, these findings elucidate the metabolic modulation upon adenoviral infection in a helper virus-induced AAV production process using stably transfected human cell lines.

systems biology↗